Bladder tumor antigen assay as compared to voided urine cytology in the diagnosis of bladder cancer

Clinica Chimica Acta

Volumn 305, Issue 1-2, 2001, Pages 47-53

  Priolo, Gabriella ^a   Gontero, Paolo ^b   Martinasso, Giovanna ^a   Mengozzi, Giulio ^a   Formiconi, Andrea ^b   Pelucelli, Gianni ^b   Zitella, Andrea ^b   Casetta, Giovanni ^b   Viberti, Laura ^b   Aimo, Giuseppe ^a   Tizzani, Alessandro ^b  

^a MOLINETTE HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Bladder cancer; BTA TRAK; Urine cytology

Indexed keywords

TUMOR ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER GRADING; CANCER RECURRENCE; CONTROLLED STUDY; CYSTOSCOPY; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN CELL; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PERFORMANCE; PRIORITY JOURNAL; REPRODUCIBILITY; URINALYSIS; URINE CYTOLOGY;

AGED; ANTIGENS, NEOPLASM; FEMALE; HUMANS; MALE; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS; URINE;

EID: 0035098798     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(00)00416-2     Document Type: Article

References (24)

1. Bladder cancer: Early diagnosis and evaluation of biological potential. A review of newer methods
2. Biology and management of bladder cancer
3. Histological typing of urinary bladder tumors
4. Superficial bladder cancer: Progression and recurrence
5. Current management of invasive and metastatic transitional cell carcinoma of the bladder
6. Evaluation of bladder washings and urine cytology in the diagnosis of bladder cancer and its correlation with selected biopses of the bladder mucosa
7. Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms
8. Diagnostic accuracy of urine cytology and deoxyribonucleic acid flow cytometry and cytology on bladder washings during follow-up for bladder tumors
9. Current concepts in biomarker technology for bladder cancers
10. Can p53 help select patients with invasive bladder cancer for bladder preservation?
11. Telomerase activity in patients with transitional cell carcinoma: A preliminary study
12. Comparison of screening methods in the detection of bladder cancer
13. Limitations of urinary telomerase activity measurement in urothelial cancer
14. Hematuria home screening: Repeat testing results
15. Use of a new tumor marker NMP22 in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment
16. Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer
17. Tumor-associated hyaluronic acid: A new sensitive and specific urine marker for bladder cancer
18. Human bladder tumor antigen is a member of the RCA (regulators of complement activation) gene family
19. Clinical evaluation of the BTA TRAK assay and comparison to voided urine cytology and the Bard BTA test in patients with recurrent bladder tumors
20. A method of comparing the areas under receiver operating characteristic curves derived from the same cases
21. The diagnostic value of urine versus bladder washing in patients with bladder cancer
22. BTA stat and BTA trak: A comparative evaluation of urine testing for the diagnosis of transitional cell carcinoma of the bladder
23. Multicenter trial of the quantitative BTA TRAK assay in the detection of bladder cancer
24. Evaluation of urinary level of NMP 22 as a diagnostic marker for stage pTa-pT1 bladder cancer; comparison with urinary cytology and BTA test